These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7086446)

  • 21. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease.
    Aguilar MV; Jiménez-Jiménez FJ; Molina JA; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Gómez-Escalonilla C; Ort-Pareja M; Zurdo M; Martínez-Para MC
    J Neural Transm (Vienna); 1998; 105(10-12):1245-51. PubMed ID: 9928893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased beta-phenylethylamine in CSF in Parkinson's disease.
    Zhou G; Shoji H; Yamada S; Matsuishi T
    J Neurol Neurosurg Psychiatry; 1997 Dec; 63(6):754-8. PubMed ID: 9416810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal.
    Adinoff B; Kramer GL; Petty F
    Psychiatry Res; 1995 Nov; 59(1-2):137-44. PubMed ID: 8771228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
    Araki K; Takino T; Ida S; Kuriyama K
    Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
    Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
    Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF GABA and neuropeptides in pathological gamblers and normal controls.
    Roy A; DeJong J; Ferraro T; Adinoff B; Gold P; Rubinow D; Linnoila M
    Psychiatry Res; 1989 Nov; 30(2):137-44. PubMed ID: 2616683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; De Bustos F; Zurdo M; Gómez-Escalonilla C; Barcenilla B; Berbel A; Camacho A; Arenas J
    J Neural Transm (Vienna); 2000; 107(4):445-9. PubMed ID: 11215755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABA levels in CSF of patients with psychiatric disorders.
    Gold BI; Bowers MB; Roth RH; Sweeney DW
    Am J Psychiatry; 1980 Mar; 137(3):362-4. PubMed ID: 7356067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical investigation of normal pressure hydrocephalus in the assessment of shunt effectiveness].
    Kanki T
    No To Shinkei; 1988 Feb; 40(2):163-70. PubMed ID: 3370169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease.
    Olanow CW; Gauger LL; Cedarbaum JM
    Ann Neurol; 1991 May; 29(5):556-9. PubMed ID: 1859185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.
    Crawford PM; Chadwick DW
    Epilepsy Res; 1987; 1(6):328-38. PubMed ID: 3504408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free and conjugated CSF and plasma GABA in Huntington's chorea.
    Uhlhaas S; Lange H; Wappenschmidt J; Olek K
    Acta Neurol Scand; 1986 Oct; 74(4):261-5. PubMed ID: 3028028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF GABA in psychotic disorders.
    Bowers MB; Gold BI; Roth RH
    Psychopharmacology (Berl); 1980; 70(3):279-82. PubMed ID: 6777800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.
    van Dijk KD; Jongbloed W; Heijst JA; Teunissen CE; Groenewegen HJ; Berendse HW; van de Berg WD; Veerhuis R
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1079-83. PubMed ID: 23932065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
    Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
    Vieira DS; Naffah-Mazacoratti MG; Zukerman E; Senne Soares CA; Alonso EO; Faulhaber MH; Cavalheiro EA; Peres MF
    Brain Res; 2006 May; 1090(1):197-201. PubMed ID: 16638608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.